pancreatic cancerpancreatic insufficiencyChronic pancreatitisRAPexocrine insufficiencydulaglutidetirzepatidesemaglutideCohort 1
…RAP (5.8% vs 10.5%; RR 0.554, 95% CI 0.487–0.631, p<0.001), and pancreatic cancer (2.0% vs 3.9%; RR 0.498, 95% CI 0.421–0.590, p<0.001). ED visit…